華潤萬象生活(1209.HK)公開發售獲近30倍超購
格隆匯12月3日丨由華潤置地(1109.HK)分拆的華潤萬象生活(1209.HK)於11月25日至12月1日招股,公司是一傢俱有極強零售消費屬性的社區及資產服務提供商與平台。據格隆匯獲悉,該股香港公開發售錄得近30倍超購,針對機構投資者的國際配售亦錄得顯著超購。此外,基石認購陣容非常豪華 ,7家基石(GIC、高領、平安、國調、Matthews、GLP),合計認購6.5億美金,佔高端綠鞋前發行規模41.1%,包含了國際及中資背景最頂級的投資機構。值得注意的是,這是今年眾多IPO發行中,國際知名主權基金GIC為數不多的幾單基石投資之一,體現了頂級投資人對公司基本面的高度認可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.